Related references
Note: Only part of the references are listed.Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies
Marilyn E. Allen et al.
TRENDS IN MOLECULAR MEDICINE (2021)
Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus
Kerry A. Casey et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Personalized Medicine in Autoimmune Diseases
Roberto Diaz-Pena
JOURNAL OF PERSONALIZED MEDICINE (2021)
A comprehensive database for integrated analysis of omics data in autoimmune diseases
Jordi Martorell-Marugan et al.
BMC BIOINFORMATICS (2021)
Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus
Haitao Yu et al.
BIOMOLECULES (2021)
Pathway-Based Drug Response Prediction Using Similarity Identification in Gene Expression
Seyed Ali Madani Tonekaboni et al.
FRONTIERS IN GENETICS (2020)
Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study
Joel M. Guthridge et al.
ECLINICALMEDICINE (2020)
Prediction of response to anti-cancer drugs becomes robust via network integration of molecular data
Marcela Franco et al.
SCIENTIFIC REPORTS (2019)
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
Jason K. Sicklick et al.
NATURE MEDICINE (2019)
Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes
Myles J. Lewis et al.
CELL REPORTS (2019)
Association between changes in gene signatures expression and disease activity among patients with systemic lupus erythematosus
Michelle Petri et al.
BMC MEDICAL GENOMICS (2019)
Neutrophils in lupus nephritis
Hiroshi Nishi et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Interferon pathway in SLE: one key to unlocking the mystery of the disease
Lars Ronnblom et al.
LUPUS SCIENCE & MEDICINE (2019)
Next generation antibody drugs: pursuit of the 'high-hanging fruit'
Paul J. Carter et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Targeting interferons and their pathways in systemic lupus erythematosus
Francois Chasset et al.
AUTOIMMUNITY REVIEWS (2018)
Stratification of Systemic Lupus Erythematosus Patients Into Three Groups of Disease Activity Progression According to Longitudinal Gene Expression
Daniel Toro-Dominguez et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids
Yanhua Hu et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Towards personalized medicine for patients with autoimmune diseases: Opportunities and challenges
Soheil Tavakolpour
IMMUNOLOGY LETTERS (2017)
Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab
Robert W. Hoffman et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Integrating personalized gene expression profiles into predictive disease-associated gene pools
Joerg Menche et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2017)
Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
D. A. Isenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
Romain Banchereau et al.
CELL (2016)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression
T. Hung et al.
SCIENCE (2015)
NbClust: AnRPackage for Determining the Relevant Number of Clusters in a Data Set
Malika Charrad et al.
Journal of Statistical Software (2015)
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines
Shuzhao Li et al.
NATURE IMMUNOLOGY (2014)
The Kidney Biopsy in Lupus Nephritis: Is It Still Relevant?
Brad H. Rovin et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2014)
Autoimmune Rheumatic Diseases 1 Clinical aspects of autoimmune rheumatic diseases
Fiona Goldblatt et al.
LANCET (2013)
The Systemic Lupus Erythematosus Responder Index (SRI); A new SLE disease activity assessment
K. M. A. C. Luijten et al.
AUTOIMMUNITY REVIEWS (2012)
Measures of Adult Systemic Lupus Erythematosus Updated Version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI)
Juanita Romero-Diaz et al.
ARTHRITIS CARE & RESEARCH (2011)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
A modular analysis framework for blood genomics studies: Application to systemic lupus erythematosus
Damien Chaussabel et al.
IMMUNITY (2008)
Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells
David Vremec et al.
BLOOD (2007)
Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus
Jason W. Bauer et al.
PLOS MEDICINE (2006)
Share Paper
